BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8958889)

  • 1. Effect of adenosine infusion on oxygen induced carbon dioxide retention in severe chronic obstructive pulmonary disease.
    Griffiths TL; Fernando SS; Saunders KB
    Thorax; 1996 Nov; 51(11):1083-6. PubMed ID: 8958889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of inspired oxygen concentration on deadspace, respiratory drive, and PaCO2 in intubated patients with chronic obstructive pulmonary disease.
    Crossley DJ; McGuire GP; Barrow PM; Houston PL
    Crit Care Med; 1997 Sep; 25(9):1522-6. PubMed ID: 9295826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of positive expiratory pressure (PEP), continuous positive airway pressure (CPAP) and hyperventilation in COPD patients with chronic hypercapnea.
    Herala M; Stålenheim G; Boman G
    Ups J Med Sci; 1995; 100(3):223-32. PubMed ID: 8808185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of transcutaneous PCO2 in monitoring chronic hypoventilation treated with non-invasive ventilation.
    Aarrestad S; Tollefsen E; Kleiven AL; Qvarfort M; Janssens JP; Skjønsberg OH
    Respir Med; 2016 Mar; 112():112-8. PubMed ID: 26874895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory response to carbon dioxide stimulation during low flow supplemental oxygen therapy in chronic obstructive pulmonary disease.
    Chiang LL; Hung TC; Ho SC; Lin HC; Yu CT; Wang CH; Kuo HP
    J Formos Med Assoc; 2002 Sep; 101(9):607-15. PubMed ID: 12645187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous continuous carbon dioxide tension monitoring reduced incidence, degree and duration of hypercapnia during combined regional anaesthesia and monitored anaesthesia care in shoulder surgery patients.
    Baulig W; Keselj M; Baulig B; Guzzella S; Borgeat A; Aguirre J
    J Clin Monit Comput; 2015 Aug; 29(4):499-507. PubMed ID: 25312782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease.
    Moloney ED; Kiely JL; McNicholas WT
    Lancet; 2001 Feb; 357(9255):526-8. PubMed ID: 11229674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conservation device for oxygen therapy in COPD.
    Evans TW; Waterhouse JC; Suggett AJ; Howard P
    Eur Respir J; 1988 Dec; 1(10):959-61. PubMed ID: 3147198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease.
    Whale CI; Sovani MP; Mortimer K; Oborne J; Cooper S; Harrison TW; Tattersfield AE
    Br J Clin Pharmacol; 2006 Aug; 62(2):153-7. PubMed ID: 16842389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease.
    Sassoon CS; Hassell KT; Mahutte CK
    Am Rev Respir Dis; 1987 Apr; 135(4):907-11. PubMed ID: 3565937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in blood gas levels after nebuhaler and nebulizer administration of terbutaline in severe chronic airway obstruction.
    Higgins RM; Cookson WO; Chadwick GA
    Bull Eur Physiopathol Respir; 1987; 23(3):261-4. PubMed ID: 3117150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD.
    Meecham Jones DJ; Paul EA; Jones PW; Wedzicha JA
    Am J Respir Crit Care Med; 1995 Aug; 152(2):538-44. PubMed ID: 7633704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of 50% oxygen on PtCO
    Pilcher J; Thayabaran D; Ebmeier S; Williams M; Back G; Collie H; Richards M; Bibby S; Semprini R; Weatherall M; Beasley R
    BMC Pulm Med; 2020 May; 20(1):125. PubMed ID: 32380988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of transcutaneous CO2 over end-tidal CO2 measurement for monitoring respiratory failure in nonintubated patients: A pilot study.
    Lermuzeaux M; Meric H; Sauneuf B; Girard S; Normand H; Lofaso F; Terzi N
    J Crit Care; 2016 Feb; 31(1):150-6. PubMed ID: 26463320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of forced expiratory volume in 1 s in screening subjects with stable COPD for PaO2 < 7.3 kPa qualifying for long-term oxygen therapy.
    Lim S; MacRae KD; Seed WA; Roberts CM
    Respir Med; 1998 Sep; 92(9):1122-6. PubMed ID: 9926166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocturnal assisted ventilation using bilevel positive airway pressure: the effect of expiratory positive airway pressure.
    Elliott MW; Simonds AK
    Eur Respir J; 1995 Mar; 8(3):436-40. PubMed ID: 7789490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of oxygen therapy on the hypercapnia in patients with chronic obstructive pulmonary disease].
    Lazić Z; Cekerevac I; Novković L; Cupurdija V
    Vojnosanit Pregl; 2008 Jul; 65(7):521-4. PubMed ID: 18700461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial blood gases in elderly persons with chronic obstructive pulmonary disease (COPD).
    Delclaux B; Orcel B; Housset B; Whitelaw WA; Derenne JP
    Eur Respir J; 1994 May; 7(5):856-61. PubMed ID: 8050540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease (COPD).
    Vos PJ; Folgering HT; de Boo TM; Lemmens WJ; van Herwaarden CL
    Eur Respir J; 1994 May; 7(5):850-5. PubMed ID: 7519567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in transcutaneous PCO2 with sleep in normal subjects and in patients with chronic respiratory diseases.
    Midgren B; Hansson L
    Eur J Respir Dis; 1987 Nov; 71(5):388-94. PubMed ID: 3127230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.